Angiodynamics (ANGO) Income from Continuing Operations (2010 - 2026)

Angiodynamics has reported Income from Continuing Operations for 17 years, with the latest figure at 8084000.0 in Q1 2026.

• For the quarter ending Q1 2026, Income from Continuing Operations fell 83.44% year-over-year to 8084000.0; the trailing twelve-month figure through Feb 2026 stood at 31387000.0 (up 24.17% YoY), and the FY2025 full-year result was 33993000.0, up 81.56% from the prior year.
• Income from Continuing Operations for Q1 2026 stood at 8084000.0, down from 6350000.0 in the prior quarter.
• The five-year high for Income from Continuing Operations was 45884000.0 in Q3 2023, with the low at 187736000.0 in Q1 2024.
• Historically, Income from Continuing Operations has averaged 18079117.65 across 5 years, with a median of 9485000.0 in 2023.
• Annual changes were most pronounced in 2023 — Income from Continuing Operations jumped 452.85% — and 2024, when it slumped 1879.29%.
• Angiodynamics' Income from Continuing Operations stood at 8486000.0 in 2022, then slumped by 242.3% to 29048000.0 in 2023, then jumped by 63.03% to 10738000.0 in 2024, then soared by 40.86% to 6350000.0 in 2025, then slipped by 27.31% to 8084000.0 in 2026.
• The last three Income from Continuing Operations figures came in at 8084000.0 (Q1 2026), 6350000.0 (Q4 2025), and 10903000.0 (Q3 2025), per Business Quant data.